Kalcipos-D


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 38.5%
Anaesthesia 15.4%
Pain 15.4%
Inhalation Therapy 7.7%
Pericarditis 7.7%
Prophylaxis 7.7%
Systemic Lupus Erythematosus 7.7%
Thrombocytopenia 50.0%
Visual Impairment 50.0%
Concomitant
Product Used For Unknown Indication 31.4%
Drug Use For Unknown Indication 12.0%
Rheumatoid Arthritis 12.0%
Osteoporosis 10.6%
Pain 8.3%
Atrial Fibrillation 2.8%
Prophylaxis 2.8%
Diabetes Mellitus 2.6%
Hypertension 2.6%
Multiple Myeloma 2.1%
Gastritis 1.8%
Cardiac Failure Chronic 1.6%
Idiopathic Thrombocytopenic Purpura 1.3%
Juvenile Arthritis 1.3%
Asthma 1.2%
Chronic Myeloid Leukaemia 1.2%
Muscle Spasms 1.2%
Osteoporosis Postmenopausal 1.2%
Depression 1.0%
Hypothyroidism 1.0%
Vomiting 11.7%
Renal Failure 7.4%
Hypotension 6.4%
Weight Increased 6.4%
Anaemia 5.3%
Hyponatraemia 5.3%
Nausea 5.3%
Skin Ulcer 5.3%
Haemorrhage 4.3%
Osteonecrosis 4.3%
Pneumonia 4.3%
Polyneuropathy 4.3%
Pyrexia 4.3%
Spinal Compression Fracture 4.3%
Thrombocytopenia 4.3%
Urinary Retention 4.3%
Amnesia 3.2%
Deep Vein Thrombosis 3.2%
Hypercalcaemia 3.2%
Infection 3.2%

Drug Data